Finance

Lists
Q3 2026 earnings • released • EPS beat +9.80%
See results
KMDA:NASDAQ
Kamada Ltd
$8.09
-0.49%
(-0.040) 1D
$8.09
0.00% (0.00)
After hours
Closed: Nov 13, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for KMDA...
Open
$8.22
High
$8.31
Low
$8.00
Mkt. cap
466.64M
Avg. vol.
102.57K
Volume
94.47K
Dividend
4.60%
Quarterly dividend
$0.09
Ex-dividend date
Aug 27, 2026
P/E ratio
21.40
52-wk high
$9.35
52-wk low
$6.60
EPS
$0.38
Beta
0.86
Shares outstanding
57.69M
No. of employees
462
Open
$8.22
High
$8.31
Low
$8.00
Mkt. cap
466.64M
Avg. vol.
102.57K
Volume
94.47K
Dividend
4.60%
Quarterly dividend
$0.09
Ex-dividend date
Aug 27, 2026
P/E ratio
21.40
52-wk high
$9.35
52-wk low
$6.60
EPS
$0.38
Beta
0.86
Shares outstanding
57.69M
No. of employees
462
News stories
From web sources and news partners
About Kamada Ltd
CEO-
Employees462
Founded1990
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitekamada.com
Analyst ratings
Based on 3 analysts giving stock ratings to KMDA in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for KMDA in the last 3 months.
Highest
Current $8.09
$15.00 (+85.41%)
Average
$13.33 (+64.81%)
Lowest
$12.00 (+48.33%)
Analyst
Recommendation
Action
Price target
Projected
Date
Annabel Samimy
Stifel Nicolaus
Buy
Reiterated
$12.00
+48.3%
11/09/2026
Andrew Fein
H.C. Wainwright
Buy
Maintained
$13.00
+60.7%
09/21/2026
Robert Wasserman
StoneX
Buy
Maintained
$15.00
+85.4%
09/18/2026
Last report
Nov 9, 2026
Fiscal period
Q3 2026
$0.14 / $0.13
+9.80%beat
Revenue / Est. (USD)
52.03M / -
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
44.68M
45.24M
54.92M
52.03M
Cost of goods sold
27.71M
26.12M
32.45M
28.70M
Cost of revenue
27.71M
26.12M
32.45M
28.70M
Research and development expenses
-18.00K
2.18M
2.20M
2.32M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
13.43M
9.98M
10.76M
10.63M
Operating expense
13.42M
12.16M
12.96M
12.96M
Total operating expenses
41.13M
38.29M
45.41M
41.66M
Operating income
3.55M
6.95M
9.51M
10.37M
Other non operating income
-142.00K
-
-
329.00K
EBT including unusual items
4.73M
5.39M
10.19M
9.71M
EBT excluding unusual items
3.33M
6.93M
9.14M
10.58M
Income tax expense
1.17M
1.26M
927.00K
1.72M
Effective tax rate
24.76%
23.35%
9.10%
17.69%
Other operating expenses
-
-
-
18.00K
Net income
3.56M
4.13M
9.26M
7.99M
Net profit margin
7.97%
9.13%
16.86%
15.36%
Earnings per share
0.06
0.07
0.16
0.14
Interest and investment income
442.00K
425.00K
434.00K
-
Interest expense
-259.00K
-188.00K
-371.00K
-238.00K
Net interest expenses
183.00K
237.00K
63.00K
-238.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
5.71M
10.80M
13.40M
14.30M
Gain or loss from assets sale
-
-
-
18.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps